Retention on Buprenorphine Is Associated with High Levels of Maximal Viral Suppression among HIV-Infected Opioid Dependent Released Prisoners
Table 3
HIV treatment outcomes for Buprenorphine group and Non-Buprenorphine group over 24 weeks.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
HIV treatment outcomes for Buprenorphine group and Non-Buprenorphine group over 24 weeks.